WO2012134168A3 - Composition for lung cancer treatment and composition for cosmetics containing lysimachiae foenumgraeci herba extract - Google Patents

Composition for lung cancer treatment and composition for cosmetics containing lysimachiae foenumgraeci herba extract Download PDF

Info

Publication number
WO2012134168A3
WO2012134168A3 PCT/KR2012/002276 KR2012002276W WO2012134168A3 WO 2012134168 A3 WO2012134168 A3 WO 2012134168A3 KR 2012002276 W KR2012002276 W KR 2012002276W WO 2012134168 A3 WO2012134168 A3 WO 2012134168A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
lung cancer
lysimachiae foenumgraeci
herba extract
cancer treatment
Prior art date
Application number
PCT/KR2012/002276
Other languages
French (fr)
Korean (ko)
Other versions
WO2012134168A2 (en
Inventor
황성연
정경채
Original Assignee
주식회사 한국전통의학연구소
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 한국전통의학연구소 filed Critical 주식회사 한국전통의학연구소
Publication of WO2012134168A2 publication Critical patent/WO2012134168A2/en
Publication of WO2012134168A3 publication Critical patent/WO2012134168A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a novel use of a lysimachiae foenumgraeci herba extract, and more specifically, to a composition for lung cancer treatment and a composition for cosmetics containing, as an active ingredient, a lysimachiae foenumgraeci herba extract having excellent preventative and treatment effects on lung cancer. The lysimachiae foenumgraeci herba extract, according to the present invention, suppresses growth of and induces apoptosis of lung cancer cells, and therefore can be used effectively for lung cancer treatment and prevention.
PCT/KR2012/002276 2011-03-28 2012-03-28 Composition for lung cancer treatment and composition for cosmetics containing lysimachiae foenumgraeci herba extract WO2012134168A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2011-0027359 2011-03-28
KR1020110027359A KR20120109138A (en) 2011-03-28 2011-03-28 Composition for treatment of lung cancer and beauty expenses composition comprising extract of lysimachiae foenumgraeci herba

Publications (2)

Publication Number Publication Date
WO2012134168A2 WO2012134168A2 (en) 2012-10-04
WO2012134168A3 true WO2012134168A3 (en) 2013-03-07

Family

ID=46932120

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/002276 WO2012134168A2 (en) 2011-03-28 2012-03-28 Composition for lung cancer treatment and composition for cosmetics containing lysimachiae foenumgraeci herba extract

Country Status (2)

Country Link
KR (1) KR20120109138A (en)
WO (1) WO2012134168A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023190943A1 (en) * 2022-03-30 2023-10-05 株式会社AutoPhagyGO Automatic purge activation agent and healthy life extension agent

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000010275A (en) * 1998-07-31 2000-02-15 성재갑 Composition for skin whitening
CN1876158A (en) * 2006-04-20 2006-12-13 朱国豪 Tujia nationality proved medicine recipe for treating cancer and tumour

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000010275A (en) * 1998-07-31 2000-02-15 성재갑 Composition for skin whitening
CN1876158A (en) * 2006-04-20 2006-12-13 朱国豪 Tujia nationality proved medicine recipe for treating cancer and tumour

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HAI-YUN LI ET AL.: "Antioxidant activity of extracts and fractions from Lysimachia foenum-graecum Hance.", BIORESOURCE TECHNOLOGY., vol. 100, no. 2, January 2009 (2009-01-01), pages 970 - 974, XP025535090, DOI: doi:10.1016/j.biortech.2008.07.021 *
IL-KWON PARK ET AL.: "In vivo fungicidal activity of medicinal plant extracts against six phytopathogenic fungi.", INTERNATIONAL JOURNAL OF PEST MANAGEMENT., vol. 54, no. 1, March 2008 (2008-03-01), pages 63 - 68 *

Also Published As

Publication number Publication date
KR20120109138A (en) 2012-10-08
WO2012134168A2 (en) 2012-10-04

Similar Documents

Publication Publication Date Title
WO2013027984A3 (en) Cosmetic composition containing green tea component
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
WO2012146584A3 (en) Specific vanillyl lignans and use thereof as taste improvers
WO2013040395A3 (en) Herbal skin care composition
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
WO2011122869A3 (en) Cosmetic composition comprising coumestrol or a bean extract containing coumestrol for skin care
WO2012134169A3 (en) Composition for lung cancer treatment and functional food containing gleditsiae semen extract
MX2014012477A (en) Pyrrolopyrazone inhibitors of tankyrase.
EP3067059A4 (en) Pharmaceutical composition for preventing or treating thyroid diseases, containing lonicera caerulea l. var. edulis fruit extract as active ingredient
WO2012002730A3 (en) Skin-whitening and skin-moisturizing composition containing bee venom extracts
WO2012027326A9 (en) Methods of treating alcohol intoxication, alcohol use disorders and alcohol abuse which comprise the administration of dihydromyricetin
WO2012134172A3 (en) Composition containing, as an active ingredient, an ethyl acetate fraction of schisandra chinensis baill, or wuweizisu c separated from the fraction, for preventing or treating obesity
WO2012108748A3 (en) Composition and cosmetic composition for treating brain cancer comprising albizzia julibrissin extract
WO2012134252A3 (en) Composition for renal cancer treatment and functional food containing cannabis semen extract
WO2012036414A3 (en) Cosmetic composition comprising a fermented soybean extract fraction as an active ingredient
WO2012134250A3 (en) Composition for renal cancer treatment and composition for cosmetic containing nardostachyos rhizoma extract
WO2012108747A3 (en) Composition and cosmetic composition for treating brain cancer comprising helena root extract
WO2012134168A3 (en) Composition for lung cancer treatment and composition for cosmetics containing lysimachiae foenumgraeci herba extract
WO2014065640A3 (en) Composition for treating or preventing inflammatory diseases containing myagropsis myagroides extract or fraction thereof as active ingredient
WO2012167903A3 (en) Cosmetic and dermatological peeling preparations
WO2012134251A3 (en) Composition for pancreatic cancer treatment and composition for cosmetics containing nardostachyos rhizoma extract
WO2012134167A3 (en) Composition for lung cancer treatment and functional food containing eriobotriae folium extract
WO2012134163A3 (en) Composition for lung cancer treatment and composition for cosmetics containing nardostachyos rhizoma extract
WO2012134170A3 (en) Composition for lung cancer treatment and composition for cosmetics containing rubiae radix extract
WO2012134165A3 (en) Composition for lung cancer treatment and composition for cosmetics containing psoraleae semen extract

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12764027

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12764027

Country of ref document: EP

Kind code of ref document: A2